ArticleVaccine2026
2023-2024 COVID-19 vaccination coverage in pregnancy in ten healthcare delivery organizations in the United States.
Article in Vaccine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Data on COVID-19 vaccination coverage in pregnancy are sparse, with most literature focused on original monovalent and bivalent vaccines. We assessed coverage of 2023-2024 COVID-19 vaccines among pregnant women across ten health care organizations in the United States participating in the Vaccine Safety Datalink (VSD). Among 167,478 women aged 18-49 years with a pregnancy during September 2023-August 2024, 23,941 (14.3%) received a 2023-2024 COVID-19 vaccine dose prior to or during their pregnancy. We identified higher coverage with increasing age groups (range 4.8% to 21.2% vaccinated) and increasing healthcare utilization during pregnancy (range 9.8% to 17.6% vaccinated). We found differences in coverage by maternal race and ethnicity (range 7.2% to 23.2% vaccinated), and by calendar month of pregnancy start (range 1.3% to 17.6% vaccinated). Uptake of 2023-2024 COVID-19 vaccines was low in this population. The VSD will continue monitoring COVID-19 vaccination coverage in pregnancy in the 2024-2025 season, including coverage by maternal race and ethnicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.